TNDM (STOCKS)
Tandem Diabetes Care, Inc.
$20.100000
+0.920000 (+4.80%)
Prev close: $19.180000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- John F. Sheridan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,372.67M
- Employees
- 2,650
- P/E (TTM)
- -6.55
- P/B (TTM)
- 8.44
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
11
Buy
12
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.01 | $-0.08 | +0.0739 | +88.08% |
|
Sep 2025 (Q3)
|
$-0.31 | $-0.32 | +0.0102 | +3.19% |
|
Jun 2025 (Q2)
|
$-0.48 | $-0.41 | -0.0761 | -18.66% |
|
Mar 2025 (Q1)
|
$-0.66 | $-0.62 | -0.0355 | -5.68% |
Financial Statements
| Revenues | $1.01B |
| Benefits Costs and Expenses | $1.22B |
| Cost Of Revenue | $468.72M |
| Costs And Expenses | $1.22B |
| Gross Profit | $546.01M |
| Operating Expenses | $733.27M |
| Selling, General, and Administrative Expenses | $444.99M |
| Depreciation and Amortization | $15.10M |
| Other Operating Expenses | $273.18M |
| Operating Income/Loss | -$187.26M |
| Income/Loss Before Equity Method Investments | -$186.08M |
| Income/Loss From Continuing Operations After Tax | -$204.71M |
| Income/Loss From Continuing Operations Before Tax | -$200.27M |
| Income/Loss From Equity Method Investments | -$14.19M |
| Income Tax Expense/Benefit | $4.44M |
| Income Tax Expense/Benefit, Current | $4.44M |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$204.71M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$204.71M |
| Net Income/Loss Available To Common Stockholders, Basic | -$204.71M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.04 |
| Diluted Earnings Per Share | -$3.04 |
| Basic Average Shares | 67,285,000 |
| Diluted Average Shares | 67,285,000 |
| Assets | $881.11M |
| Current Assets | $618.14M |
| Inventory | $128.77M |
| Other Current Assets | $489.37M |
| Noncurrent Assets | $262.97M |
| Fixed Assets | $83.58M |
| Other Non-current Assets | $179.39M |
| Liabilities | $725.94M |
| Current Liabilities | $242.72M |
| Accounts Payable | $47.07M |
| Wages | $70.41M |
| Other Current Liabilities | $125.25M |
| Noncurrent Liabilities | $483.22M |
| Commitments and Contingencies | $0.00 |
| Equity | $155.17M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $155.17M |
| Liabilities And Equity | $881.11M |
| Net Cash Flow From Operating Activities | -$9.72M |
| Net Cash Flow From Operating Activities, Continuing | -$9.72M |
| Net Cash Flow From Investing Activities | $72.88M |
| Net Cash Flow From Investing Activities, Continuing | $72.88M |
| Net Cash Flow From Financing Activities | -$43.37M |
| Net Cash Flow From Financing Activities, Continuing | -$43.37M |
| Exchange Gains/Losses | $1.61M |
| Net Cash Flow | $21.40M |
| Net Cash Flow, Continuing | $19.79M |
| Comprehensive Income/Loss | -$197.17M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$197.17M |
| Other Comprehensive Income/Loss | $7.54M |